Because SDC-2 has been associated with tumorigenicity in sarcoma, fibrosarcoma, melanoma and colon cancer cells [20,29-31], we set out to determine whether modulation of SDC-2 expression in pancreatic cancer cells would affect their motility and their invasive capacity in vitro. The gene discussed is SDC2; the disease is familial pancreatic carcinoma.